Cargando…

Plasma Galectin-3 is associated with progression from paroxysmal to persistent atrial fibrillation

BACKGROUND: Galectin-3 (Gal-3) is currently recognized as a promising biomarker for myocardial fibrosis. This study aimed to explore the potential association between plasma Gal-3 concentrations and atrial fibrillation (AF) progression in paroxysmal AF (PAF) patients METHODS: A total of 213 PAF pati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Qianhui, Xu, Li, Dong, Ying, Fu, Yuan, Pan, Yuxia, Luan, Qianran, Liu, Ye, Liu, Zheng, Yang, Xinchun, Chen, Mulei, Gao, Yuanfeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8091760/ https://www.ncbi.nlm.nih.gov/pubmed/33934700 http://dx.doi.org/10.1186/s12872-021-02043-0

Ejemplares similares

Leukocyte Telomere Length Predicts Progression From Paroxysmal to Persistent Atrial Fibrillation in the Long Term After Catheter Ablation
por: Wang, Qianhui, et al.
Publicado: (2022)

Circulating plasma galectin-3 predicts new-onset atrial fibrillation in patients after acute myocardial infarction during hospitalization
por: Wang, Qianhui, et al.
Publicado: (2022)

The potential regulatory role of hsa_circ_0004104 in the persistency of atrial fibrillation by promoting cardiac fibrosis via TGF-β pathway
por: Gao, Yuanfeng, et al.
Publicado: (2021)

Shortened leukocyte telomere length as a potential biomarker for predicting the progression of atrial fibrillation from paroxysm to persistence in the short-term
por: Wang, Siyu, et al.
Publicado: (2021)

Predictive value of CHA2DS2-VASc score combined with hs-CRP for new-onset atrial fibrillation in elderly patients with acute myocardial infarction
por: Fu, Yuan, et al.
Publicado: (2021)

Prevalence and determinants of atrial fibrillation progression in paroxysmal atrial fibrillation
por: Nguyen, Bao-Oanh, et al.
Publicado: (2023)

Understanding the transition from paroxysmal to persistent atrial fibrillation
por: Ciacci, Alberto, et al.
Publicado: (2020)

Association of atrial arrhythmias with thrombospondin-1 in patients with acute myocardial infarction
por: Liao, Wenkai, et al.
Publicado: (2021)

Angiotensin receptor-neprilysin inhibitor delays progression from paroxysmal to persistent atrial fibrillation
por: Dong, Youzheng, et al.
Publicado: (2023)

Left atrial effective conducting size predicts atrial fibrillation vulnerability in persistent but not paroxysmal atrial fibrillation
por: Williams, Steven E., et al.
Publicado: (2019)

Left atrial remodeling: Regional differences between paroxysmal and persistent atrial fibrillation
por: Kogawa, Rikitake, et al.
Publicado: (2017)

Thromboembolic risks associated with paroxysmal and persistent atrial fibrillation in Asian patients: a report from the Chinese atrial fibrillation registry
por: Wang, Ying, et al.
Publicado: (2019)

Persistent Atrial Fibrillation Is Associated with Worse Prognosis Than Paroxysmal Atrial Fibrillation in Acute Cerebral Infarction
por: Naess, Halvor, et al.
Publicado: (2012)

Predisposing Factors Associated With Development of Persistent Compared With Paroxysmal Atrial Fibrillation
por: Sandhu, Roopinder K., et al.
Publicado: (2014)

Outcomes of cryoballoon or radiofrequency ablation in symptomatic paroxysmal or persistent atrial fibrillation
por: Hoffmann, Ellen, et al.
Publicado: (2019)

Left Atrial Dysfunction, Fibrosis and the Risk of Thromboembolism in Patients With Paroxysmal and Persistent Atrial Fibrillation
por: Kim, Hee-Dong, et al.
Publicado: (2022)

Identification of atrial complex electrograms by short-coupled extrastimuli in paroxysmal and persistent atrial fibrillation
por: Silva, E, et al.
Publicado: (2023)

Early effects of paroxysmal atrial fibrillation on plasma markers of fibrinolysis
por: Negreva, Mariya, et al.
Publicado: (2016)

Disordered gut microbiota and alterations in metabolic patterns are associated with atrial fibrillation
por: Zuo, Kun, et al.
Publicado: (2019)

Cryoballoon ablation of the left atrial posterior wall reduces recurrence of persistent atrial fibrillation in patients with non‐paroxysmal atrial fibrillation
por: Shigeta, Takatoshi, et al.
Publicado: (2021)

Cryoballoon ablation for paroxysmal atrial fibrillation in a case of persistent left superior vena cava
por: Huang, Shiwei, et al.
Publicado: (2018)

Predictive value of noninducibility after catheter ablation for paroxysmal and persistent atrial fibrillation
por: Tachibana, Shinichi, et al.
Publicado: (2020)

Duration of Persistent Atrial Fibrillation Is Associated with Alterations in Human Gut Microbiota and Metabolic Phenotypes
por: Zuo, Kun, et al.
Publicado: (2019)

Biomarkers of Atrial Fibrillation Recurrence in Patients with Paroxysmal or Persistent Atrial Fibrillation Following External Direct Current Electrical Cardioversion
por: Demirel, Ozan, et al.
Publicado: (2023)

Moving catheter ablation forward from paroxysmal to persistent atrial fibrillation: progress, limitations, and surprises of the SARA trial
por: Hindricks, Gerhard, et al.
Publicado: (2014)

Left atrial dimensions and left atrial appendage morphology: differences in paroxysmal versus persistent atrial fibrillation patients
por: Pongratz, J, et al.
Publicado: (2023)

Suppression of Paroxysmal Atrial Fibrillation by Pacing
por: Gupta, Anoop K
Publicado: (2003)

Paroxysmal atrial fibrillation in cryptogenic stroke
por: Dangayach, Neha S, et al.
Publicado: (2011)

Hypoadiponectinemia in Patients With Paroxysmal Atrial Fibrillation
por: Choi, Byung Joo, et al.
Publicado: (2012)

Structural and electrophysiological determinants of atrial cardiomyopathy identify remodeling discrepancies between paroxysmal and persistent atrial fibrillation
por: Huang, Taiyuan, et al.
Publicado: (2023)

The predictive value of galectin‐3 levels on left atrial low voltage areas assessed by high‐density mapping in patients with paroxysmal atrial fibrillation
por: Aksan, Gökhan, et al.
Publicado: (2022)

An echocardiographic model for predicting the recurrence of paroxysmal atrial fibrillation after circumferential pulmonary vein ablation
por: Miao, Yuxia, et al.
Publicado: (2021)

Difference in risk factors of silent brain infarction between paroxysmal and persistent atrial fibrillation
por: Kim, Andrew T, et al.
Publicado: (2021)

Transcriptome analysis reveals key pathways that vary in patients with paroxysmal and persistent atrial fibrillation
por: Sun, Haoliang, et al.
Publicado: (2021)

Long-term Prognosis of Paroxysmal Atrial Fibrillation and Predictors for Progression to Persistnt or Chronic Atrial Fibrillation in the Korean Population
por: Im, Sung II, et al.
Publicado: (2015)

Anatomical and electrophysiological factors involved in atrial cardiomyopathy identify remodeling discrepancies between paroxysmal and persistent atrial fibrillation
por: Huang, T, et al.
Publicado: (2023)

The Impact of Sleep Disturbance on Gut Microbiota, Atrial Substrate, and Atrial Fibrillation Inducibility in Mice: A Multi-Omics Analysis
por: Zuo, Kun, et al.
Publicado: (2022)

Could successful cryoballoon ablation of paroxysmal atrial fibrillation prevent progressive left atrial remodeling?
por: Erdei, Tamás, et al.
Publicado: (2012)

Natriuretic peptides for the detection of paroxysmal atrial fibrillation
por: Seegers, Joachim, et al.
Publicado: (2015)

Balloon Cryoablation for the Treatment of Paroxysmal Atrial Fibrillation
por: Fenelon, Guilherme, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_cdf4ue4mc8nco5mk2rires09r6